St. Jude Medical, Inc. (STJ) Reports Mostly Inline Q2 Results; Guides Q3, FY11 EPS
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q2 EPS of $0.85, $0.01 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.45 billion.
Sees Q3 2011 EPS of $0.74-$0.76, versus the consensus of $0.80.
Sees FY2011 EPS of $3.25-$3.30, versus the consensus of $3.30.
Sees Q3 2011 EPS of $0.74-$0.76, versus the consensus of $0.80.
Sees FY2011 EPS of $3.25-$3.30, versus the consensus of $3.30.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Twin Disc (TWIN) Tops Q4 EPS by 16c
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
